Chad Briscoe

678 total citations
11 papers, 263 citations indexed

About

Chad Briscoe is a scholar working on Immunology, Molecular Biology and Physiology. According to data from OpenAlex, Chad Briscoe has authored 11 papers receiving a total of 263 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 4 papers in Molecular Biology and 3 papers in Physiology. Recurrent topics in Chad Briscoe's work include Biosimilars and Bioanalytical Methods (9 papers), Clinical Laboratory Practices and Quality Control (3 papers) and Protein purification and stability (2 papers). Chad Briscoe is often cited by papers focused on Biosimilars and Bioanalytical Methods (9 papers), Clinical Laboratory Practices and Quality Control (3 papers) and Protein purification and stability (2 papers). Chad Briscoe collaborates with scholars based in United States. Chad Briscoe's co-authors include David S. Hage, Mark R. Stiles, Michelle Ji Yeon Yoo, Rangan Mallik, Veniamin N. Lapko, Richard W. Olsen, Yousef J. Basir, Jean W. Lee, Timothy Sangster and Rafiq Islam and has published in prestigious journals such as Journal of Chromatography A, Rapid Communications in Mass Spectrometry and Journal of Pharmaceutical and Biomedical Analysis.

In The Last Decade

Chad Briscoe

9 papers receiving 248 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chad Briscoe United States 5 104 82 52 44 42 11 263
Keith L. Hoffman United States 9 65 0.6× 62 0.8× 37 0.7× 29 0.7× 44 1.0× 21 320
Ludovic Bailly‐Chouriberry France 12 170 1.6× 80 1.0× 31 0.6× 50 1.1× 14 0.3× 41 417
Jonathan Kehler United States 13 167 1.6× 118 1.4× 73 1.4× 23 0.5× 19 0.5× 17 385
Hermes Licea‐Perez United States 12 154 1.5× 134 1.6× 61 1.2× 62 1.4× 66 1.6× 24 461
Bruce Stouffer United States 11 70 0.7× 33 0.4× 42 0.8× 13 0.3× 56 1.3× 22 253
Bénédicte Duretz France 6 146 1.4× 130 1.6× 39 0.8× 50 1.1× 60 1.4× 7 361
Christophe Husser Switzerland 10 183 1.8× 170 2.1× 18 0.3× 42 1.0× 41 1.0× 20 356
Debra A. McLoughlin United States 9 88 0.8× 130 1.6× 26 0.5× 55 1.3× 39 0.9× 12 290
Günter Gmeiner Austria 15 148 1.4× 120 1.5× 15 0.3× 35 0.8× 18 0.4× 45 601
Jennifer L. H. Johnson United States 10 54 0.5× 68 0.8× 16 0.3× 26 0.6× 26 0.6× 16 412

Countries citing papers authored by Chad Briscoe

Since Specialization
Citations

This map shows the geographic impact of Chad Briscoe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chad Briscoe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chad Briscoe more than expected).

Fields of papers citing papers by Chad Briscoe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chad Briscoe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chad Briscoe. The network helps show where Chad Briscoe may publish in the future.

Co-authorship network of co-authors of Chad Briscoe

This figure shows the co-authorship network connecting the top 25 collaborators of Chad Briscoe. A scholar is included among the top collaborators of Chad Briscoe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chad Briscoe. Chad Briscoe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Briscoe, Chad. (2019). Perspectives on Gender Parity in Bioanalysis: An Interview with Chad Briscoe. Bioanalysis. 11(7). 659–660.
2.
Briscoe, Chad. (2019). Assessing Stability in Bioanalysis: Reflections on the Last 10 Years. Bioanalysis. 11(7). 579–582. 4 indexed citations
3.
Briscoe, Chad & Rafiq Islam. (2019). Stability Issues in Bioanalysis. Bioanalysis. 11(20). 1813–1814. 1 indexed citations
4.
Briscoe, Chad, et al.. (2017). Method Transfer: A CRO Perspective. Bioanalysis. 9(15). 1131–1134.
5.
Briscoe, Chad, et al.. (2013). Ask The Experts: Increasing and Maintaining Productivity in The Bioanalytical Laboratory. Bioanalysis. 5(14). 1715–1722. 3 indexed citations
6.
Mallik, Rangan, Michelle Ji Yeon Yoo, Chad Briscoe, & David S. Hage. (2010). Analysis of drug–protein binding by ultrafast affinity chromatography using immobilized human serum albumin. Journal of Chromatography A. 1217(17). 2796–2803. 60 indexed citations
7.
Hayes, Michael, Lakshmi Amaravadi, Mark E. Arnold, et al.. (2010). Conference Report: Summary of The Eleventh Annual University of Wisconsin Land O’Lakes Bioanalytical Conference. Bioanalysis. 2(10). 1677–1681. 1 indexed citations
8.
Briscoe, Chad. (2009). Advances in the application of high performance affinity chromatography to bioanalysis and approaches for improving the quality and reliability of bioanalytical data. Insecta mundi. 2 indexed citations
9.
Briscoe, Chad & David S. Hage. (2009). Factors Affecting the Stability of Drugs and Drug Metabolites in Biological Matrices. Bioanalysis. 1(1). 205–220. 59 indexed citations
10.
Briscoe, Chad, Mark R. Stiles, & David S. Hage. (2007). System suitability in bioanalytical LC/MS/MS. Journal of Pharmaceutical and Biomedical Analysis. 44(2). 484–491. 80 indexed citations
11.
Lapko, Veniamin N., et al.. (2006). A general approach for the quantitative analysis of bisphosphonates in human serum and urine by high‐performance liquid chromatography/tandem mass spectrometry. Rapid Communications in Mass Spectrometry. 20(22). 3421–3426. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026